Aquestive Pharma (AQST): Rasio rega marang prakiraan pendapatan
Tracking the forward P/S valuation history on GURU.Markets, we note that 10.20 serves as the current level of the metric for Aquestive Therapeutics (AQST). This trend reflects the company's ownership of exclusive patents for drug-films that generate steady income, alongside the growing prestige of the brand as an innovation leader. Robotic factories with AI control, which completely eliminate manual labor during production, further solidify the business efficiency.
Rincian analitis perusahaan Aquestive Therapeutics
- rega saiki lan proyeksi nilai saham:
- data kapitalisasi bursa:
- indikator nilai buku ekuitas:
- rincian utang lan likuiditas:
Utang marang Ekuitas Aquestive Therapeutics|AQST - Rasio tanggungan utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Aquestive Therapeutics|AQST - Tanggungan utang kumulatif perusahaan|Utang-utang marang kapitalisasi buku Aquestive Pharma|AQST - Gunggunge utang jangka dawa|Kewajiban jangka cendhak perusahaan Aquestive Therapeutics|Rasio cepet aquestive.com
- indikator pendapatan resik lan kelipatan nilai:
AQST - Penghasilan resik perusahaan|Bathi mangsa ngarep Aquestive Therapeutics|AQST - Nilai perusahaan marang bathi resik|Prakiraan rega marang bathi Aquestive Pharma|AQST - Rasio nilai perusahaan marang wutah bathi|Pangali EV/EBITDA Aquestive Therapeutics Inc|AQST - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Aquestive Therapeutics|AQST - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan aquestive.com|AQST - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Aquestive Therapeutics
- data total pendapatan lan volume dodolan:
Analisis umum perusahaan:Aquestive Corp AQST
Aquestive Therapeutics (AQST) operates in the high-risk drug delivery systems segment. By analyzing the projected P/S trend, an investor assesses market capitalization dynamics relative to expected revenue. This forward-looking multiple measures the recovery speed of the business valuation and the market's level of confidence in future cash flows. For Aquestive Therapeutics (AQST), this is a critical indicator of resilience in the face of regulatory uncertainties and capital shortages before reaching break-even.
Analisis perusahaan pesaing
Multiplikator Forward P/S HLN (Haleon PLC)|Multiplikator Forward P/S Kenvue Corp KVUE|Verona Pharma PLC - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep jyongbio.com|LGND: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan AMRX|Rasio rega marang prakiraan pendapatan Perrigo Company|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Alvotech ALVO|Multiplikator Forward P/S LQDA|GLPG: Rega mangsa ngarep marang pendapatan|Multiplikator Forward P/S ANIP (ANI Pharmaceuticals, Inc.)|Rasio kapitalisasi marang dodolan sing dikarepake MannKind Corp (MNKD)|AMPH: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan PCRX (Pacira)|ARS Pharmaceuticals (SPRY) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan TBPH|SCPH (scpharmaceuticals.com) - Multiplikator Forward P/S|TECX: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Tonix Pharmaceuticals Inc. (TNXP)|SXTC (SXT Pharmaceuticals) - Rega forward marang dodolan|Multiplikator Forward P/S EPRX (Eupraxia Pharmaceuticals)|Rega forward marang dodolan BHST|Invizyne Technologies - Multiplikator Forward P/S|oramed.com (ORMP) - Multiplikator forward rega marang pendapatan|ENTX (enterabio.com) - Multiplikator forward rega marang pendapatan|Kapitalisasi marang prakiraan pendapatan HYFT|ABVC (ABVC BioPharma, Inc) - Multiplikator Forward P/S|Multiplikator Forward P/S cumberlandpharma.com|Rasio rega marang prakiraan pendapatan Quantum BioPharma (QNTM)|FibroGen (FGEN) - Prakiraan rega marang pendapatan|Multiplikator Forward P/S TELO (telomirpharma.com)|RANI - Multiplikator forward rega marang pendapatan|SNYR - Rasio rega marang prakiraan pendapatan|rallybio.com - Rasio rega marang pendapatan sing dikarepake|LEXX: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Pulmatrix Inc|PTHL (Pheton Holdings) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Aptorum Group Limited APM|Rasio rega marang prakiraan pendapatan Lyra Therapeutics (LYRA)|Multiplikator forward rega marang pendapatan Impact BioMedical Inc IBO|Rasio rega marang prakiraan pendapatan tnfpharma.com TNFA|Rega forward marang dodolan YCBD|PainReform Ltd - Multiplikator Forward P/S|Altamira Therapeutics Ltd (CYTO) - Multiplikator forward rega marang pendapatan|lipella.com (LIPO) - Rasio rega marang prakiraan pendapatan|OptiNose (OPTN) - Multiplikator Forward P/S|PIRS (Pieris Pharmaceuticals Inc) - Multiplikator Forward P/S|PROC: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Petros Pharmaceuticals, Inc. (PTPI)|Multiplikator Forward P/S Qilian International Corp (QLI)|ACELYRIN, Inc. - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S tffpharma.com TFFP
